ClinicalTrials.govpublic full text
Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia
recurrent t-cell prolymphocytic leukemia, t-cell prolymphocytic leukemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 238114
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.